Group 1 - The core viewpoint of the articles highlights the performance and financial metrics of He Shi Eye Hospital Group, indicating a recent stock price increase and a decline in shareholder numbers [1][2] - As of May 16, the closing stock price of He Shi Eye Hospital was 20.78 yuan, up by 1.02%, with a latest price-to-book ratio of 1.72, marking a new low in 13 days and a total market capitalization of 3.284 billion yuan [1] - The company reported a revenue of 291 million yuan for Q1 2025, representing a year-on-year increase of 2.35%, and a net profit of 32.53 million yuan, which is a 12.27% increase year-on-year, with a gross profit margin of 43.80% [1] Group 2 - The company has 9,399 shareholders as of March 31, 2025, a decrease of 392 shareholders from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - He Shi Eye Hospital's main business focuses on personalized and intelligent eye health management services, including refractive surgery, cataract treatment, retinal disease treatment, and other eye disease treatments [1] - The company's price-to-earnings (P/E) ratio is significantly lower than the industry average, with a trailing P/E of -137.73 compared to the industry average of 37.33 [2]